603168 Stock Overview
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Risk Analysis
No risks detected for 603168 from our risk checks.
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥7.91 |
| 52 Week High | CN¥14.04 |
| 52 Week Low | CN¥5.90 |
| Beta | 0.44 |
| 11 Month Change | -5.16% |
| 3 Month Change | 25.76% |
| 1 Year Change | -24.95% |
| 33 Year Change | -11.72% |
| 5 Year Change | 7.33% |
| Change since IPO | 14.40% |
Recent News & Updates
Shareholder Returns
| 603168 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -3.5% | -0.6% | -2.8% |
| 1Y | -25.0% | -8.7% | 2.0% |
Return vs Industry: 603168 underperformed the CN Pharmaceuticals industry which returned -8.7% over the past year.
Return vs Market: 603168 underperformed the CN Market which returned 2% over the past year.
Price Volatility
| 603168 volatility | |
|---|---|
| 603168 Average Weekly Movement | 9.1% |
| Pharmaceuticals Industry Average Movement | 7.4% |
| Market Average Movement | 8.4% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 603168 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 603168's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1978 | 1,385 | n/a | www.zjspas.com |
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of pharmaceutical products. The company provides its products to ophthalmology, antimicrobials, gynecology, and other classes.
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Fundamentals Summary
| 603168 fundamental statistics | |
|---|---|
| Market cap | CN¥2.98b |
| Earnings (TTM) | -CN¥84.79m |
| Revenue (TTM) | CN¥505.58m |
5.9x
P/S Ratio-35.1x
P/E RatioIs 603168 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 603168 income statement (TTM) | |
|---|---|
| Revenue | CN¥505.58m |
| Cost of Revenue | CN¥247.66m |
| Gross Profit | CN¥257.91m |
| Other Expenses | CN¥342.71m |
| Earnings | -CN¥84.79m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.23 |
| Gross Margin | 51.01% |
| Net Profit Margin | -16.77% |
| Debt/Equity Ratio | 12.2% |
How did 603168 perform over the long term?
See historical performance and comparison